Randomized phase II study of neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed primary glioblastoma multiforme.

被引：0
|
作者：
Hofland, K. F.
Hansen, S.
Sorensen, M.
Schultz, H. P.
Muhic, A.
Engelholm, S.
Ask, A.
Kristiansen, C.
Thomsen, C.
Poulsen, H. Skovgaard
Lassen, U. N.
机构：
[1] Rigshosp, Dept Oncol, Finsenctr 5073, DK-2100 Copenhagen, Denmark
[2] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
[3] NBG, Onkol Afdeling D, Aarhus, Denmark
[4] Roskilde Hosp, Dept Oncol, Copenhagen, Denmark
[5] Dept Oncol Malmoe Lund, Lund, Sweden
[6] Rigshosp, Ctr Diagnost, Dept Radiol, DK-2100 Copenhagen, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2052
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
    Balana, Carmen
    De Las Penas, Ramon
    Manuel Sepulveda, Juan
    Gil-Gil, Miguel J.
    Luque, Raquel
    Gallego, Oscar
    Carrato, Cristina
    Sanz, Carolina
    Reynes, Gaspar
    Herrero, Ana
    Luis Ramirez, Jose
    Perez-Segura, Pedro
    Berrocal, Alfonso
    Maria Vieitez, Jose
    Garcia, Almudena
    Vazquez-Estevez, Sergio
    Peralta, Sergi
    Fernandez, Isaura
    Henriquez, Ivan
    Martinez-Garcia, Maria
    Jose De la Cruz, Juan
    Capellades, Jaume
    Giner, Pilar
    Villa, Salvador
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (03) : 569 - 579
  • [32] A multicenter exploratory phase II study of neoadjuvant bevacizumab for newly diagnosed glioblastoma - the second report
    Tanaka, Toshihide
    Takei, Jun
    Tamura, Ryota
    Yamamoto, Yohei
    Akasaki, Yasuharu
    Miyake, Keisuke
    Sasaki, Hikaru
    CANCER SCIENCE, 2024, 115 : 677 - 677
  • [33] Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma
    Peters, Katherine B.
    Lou, Emil
    Desjardins, Annick
    Reardon, David A.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Friedman, Henry S.
    Vredenburgh, James J.
    ONCOLOGIST, 2015, 20 (07): : 727 - 728
  • [34] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Phase II trial of radiation therapy/temozolomide/bevacizumab followed by bevacizumab/everolimus in the first- line treatment of glioblastoma multiforme (GBM)
    Shih, K. C.
    Spigel, D. R.
    Burris, H. A., III
    Brown, R. H.
    Shepard, G. C.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
    Brewer, CJ
    Suh, JH
    Stevens, GHJ
    Barnett, GH
    Toms, S
    Vogelbaum, MA
    Weil, R
    Peereboom, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
  • [37] Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Saris, G
    Beroukas, K
    Karageorgis, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2372 - 2377
  • [38] A PHASE II STUDY OF MULTIMODAL THERAPY EMPLOYING SURGERY, CARMUSTINE (BCNU) WAFER, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Rezazadeh, Arash
    LaRocca, Renato V.
    Vitaz, Todd W.
    Villanueva, Wayne G.
    Hodes, Jonathan
    Haysley, Leslie
    NEURO-ONCOLOGY, 2011, 13 : 90 - 90
  • [39] A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMA
    Sumrall, Ashley
    Haggstrom, Daniel
    Burri, Stuart
    Symanowski, James
    NEURO-ONCOLOGY, 2017, 19 : 16 - 16
  • [40] FEASIBILITY OF COMBINED TREATMENT WITH BEVACIZUMAB, RADIOTHERAPY, AND TEMOZOLOMIDE IN RESECTABLE AND UNRESECTABLE NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    van Linde, Myra E.
    Verhoeff, Joost J. C.
    Stalpers, Lukas J. A.
    Reijneveld, Jaap C.
    Richel, Dirk J.
    Van Furth, Wouter Ralph
    NEURO-ONCOLOGY, 2009, 11 (05) : 628 - 628
12345